What is Insulinaemia?
Insulinaemia (or hyperinsulinemia) refers to elevated levels of insulin in the blood, which can occur even when blood glucose levels are normal or elevated. 1
Definition and Clinical Context
Insulinaemia represents a state where circulating insulin concentrations are higher than expected for a given glucose level. This condition is fundamentally distinct from simply measuring insulin—it implies an abnormal elevation that reflects underlying metabolic dysfunction. 2
Key Characteristics:
Can exist with normal glucose levels: Hyperinsulinemia may maintain euglycemia (normal blood sugar) for extended periods through compensatory mechanisms before beta-cell function deteriorates. 2
Reflects insulin resistance: The elevated insulin levels typically represent the body's attempt to overcome tissue resistance to insulin's effects, requiring higher concentrations to achieve the same metabolic response. 2
Selective signaling impairment: While glucose uptake may be impaired ("insulin resistance"), other insulin actions—including promotion of protein synthesis, de novo lipogenesis, cell proliferation, and inhibition of lipolysis—remain largely unrestricted. 3
Pathophysiological Context in Diabetes
Type 2 Diabetes Presentation:
In type 2 diabetes, patients characteristically present with insulin levels that appear normal or even elevated despite hyperglycemia. 4, 5, 6 This paradox reflects a relative insulin deficiency—the insulin secretion is inadequate to compensate for the degree of insulin resistance present. 5
The higher blood glucose levels would be expected to produce even higher insulin values if beta-cell function were normal. 4, 5
This represents defective insulin secretion that is insufficient to overcome peripheral insulin resistance. 5
Ethnic Variations:
Black African populations demonstrate a particularly pronounced hyperinsulinemic phenotype characterized by higher insulin secretion and lower insulin clearance compared to White Europeans, largely independent of differences in adiposity and insulin sensitivity. 7 This trait appears highly conserved across indigenous and diasporic populations. 7
Primary Causes and Risk Factors
Insulin Resistance-Related:
Obesity and visceral adiposity: The most common driver, with excess visceral fat releasing free fatty acids, inflammatory cytokines, and adipokines that impair insulin signaling. 1, 2, 8
Physical inactivity: Independently promotes insulin resistance by reducing glucose transporter expression and impairing insulin signaling in skeletal muscle. 1, 2
Metabolic syndrome: Features compensatory hyperinsulinemia even in normoglycemic states, termed "euglycemic dysmetabolism." 1
Genetic Factors:
Family history: First-degree relatives of diabetic patients demonstrate insulin resistance and hyperinsulinemia even before developing hyperglycemia. 2
MODY: Monogenetic defects in beta-cell function can lead to abnormal insulin dynamics. 1
Mitochondrial DNA mutations: Associated with diabetes and altered insulin metabolism. 1
Dietary and Lifestyle:
- Western diet: High in calories and carbohydrates, directly promotes hyperinsulinemia and creates a vicious cycle through increased de novo lipogenesis. 1
Endocrine Disorders:
- Endocrinopathies: Conditions like acromegaly, Cushing's syndrome, glucagonoma, and pheochromocytoma antagonize insulin action, leading to compensatory hyperinsulinemia. 1
Clinical Significance and Consequences
Metabolic Complications:
Hyperinsulinemia is associated with multiple metabolic disorders beyond glucose dysregulation: 9
- Central obesity 9
- Hypertension 8, 9, 10
- Dyslipidemia 9
- Nonalcoholic fatty liver disease 9
- Polycystic ovary syndrome 9
- Sleep apnea 9
- Renal failure 9
Cardiovascular Risk:
Hyperinsulinemia independently increases cardiovascular disease risk, atherosclerosis risk, and overall mortality. 2, 9, 3 Mendelian randomization studies demonstrate a causal link between genetically determined high insulin production and increased cardiovascular disease risk. 3
The "Hyperinsulinemic Syndrome" Concept:
Evidence suggests that disorders traditionally grouped under "metabolic syndrome" share hyperinsulinemia as a common etiology, leading to the proposed concept of a unified "hyperinsulinemic syndrome." 9
Critical Clinical Pitfalls
Normal Glucose Does Not Exclude Hyperinsulinemia:
The most important caveat is that normal blood glucose readings do not exclude hyperinsulinemia or insulin resistance. 1, 2 Compensatory hyperinsulinemia can maintain euglycemia for years before beta-cell decompensation occurs and hyperglycemia develops. 2
Insulin as Both Consequence and Driver:
Hyperinsulinemia is not merely a compensatory response—it can itself drive and perpetuate insulin resistance, creating a self-reinforcing cycle. 11, 3 Studies show that:
- Mice with genetically elevated insulin levels develop insulin resistance, hyperglycemia, and hypertriglyceridemia despite normal weight. 11
- Escalating insulin doses in rats and humans induce both hyperinsulinemia and worsening insulin resistance. 11
- Patients with insulinoma demonstrate reduced insulin responsiveness. 11
Ethnic-Specific Considerations:
Asian Americans develop insulin resistance and diabetes at lower BMI thresholds (≥23 kg/m²), requiring adjusted screening criteria compared to other populations. 6, 2
Assessment Approach
When evaluating for insulinaemia in adults with diabetes or insulin resistance history:
Assess body composition: Focus on central/visceral adiposity rather than total body weight, as visceral fat specifically correlates with insulin resistance severity. 1, 2
Screen for metabolic syndrome components: Evaluate for hypertension, dyslipidemia, and impaired glucose tolerance as clustering significantly increases cardiovascular risk. 1, 2
Consider endocrine disorders: Particularly in patients with characteristic clinical features suggesting conditions like Cushing's syndrome or acromegaly. 1
Evaluate dietary patterns: High-carbohydrate and hypercaloric diets are key modifiable contributors. 1
Measure fasting insulin and glucose: Calculate indices like HOMA-IR (Homeostatic Model Assessment for Insulin Resistance) to quantify insulin resistance, though direct insulin measurement may not always be necessary for clinical management. 10